Hot Keywords
non-alcoholic fatty liver disease epidemiology microenvironment nonalcoholic steatohepatitis transplantation cholangiocarcinoma direct-acting antiviral immunotherapy hepatitis B hepatitis C liver resection imaging cancer stem cell diagnosis gene cirrhosis biomarker recurrence

Topic: Management of Huge and Advanced Hepatocellular Carcinoma

A special issue of Hepatoma Research

ISSN 2454-2520 (Online), ISSN 2394-5079 (Print)

Submission deadline: 28 Feb 2018

Guest Editor(s)

  • Kenneth Siu Ho Chok, MBBS (HK), MS (HK), FRCSEd, FCSHK, FHKAM (Surgery)
    Division of Hepatobiliary and Pancreatic Surgery and Liver Transplantation, Department of Surgery, The University of Hong Kong, Hong Kong, China.


Special Issue Introduction

Hepatocellular carcinoma (HCC) remains a major health burden – especially in regions with endemic hepatitis B – with more than 500,000 cases diagnosed annually. Unfortunately, most patients are diagnosed when their disease has progressed to a late stage and their liver reserve has become very limited, making surgical resection extremely difficult, if not impossible. The current special issue focuses on a wide range of practical tips. Topics involve recent advances in diagnosis by using Primovistmagnetic resonance imaging scan, control of hepatitis B virus and HCC related to the virus with the use of latest antiviral agents, minimally invasive hepatectomy by laparoscopy and with robot-assistance, and management of advanced/huge hepatoma with vascular resection and reconstruction. With contributions from all experts in the field, we will win the battle against HCC in the future.

Submission Deadline

28 Feb 2018

Submission Information

Articles of special issue are free of charge for article processing.
For Author Instructions, please refer to
For Online Submission, please login at
Submission Deadline: 28 Feb 2018
Contacts: Lijun Jin, Managing Editor,

Published Articles

© 2016-2022 OAE Publishing Inc., except certain content provided by third parties